Dr. Sue Rosenberg joins BriaCell Scientific Advisory Board
Suzanne Ostrand-Rosenberg, Professor Emerita, has joined the BriaCell Scientific Advisor Board. BriaCell is a a clinical-stage biotechnology company specializing in targeted immunotherapies for advanced breast cancer and other cancers.